Understanding the revolutionary HIV medication and Taj Pharma's role in global health
Dolutegravir is a modern antiretroviral medication that has revolutionized HIV treatment globally. It belongs to a class of drugs called integrase strand transfer inhibitors (INSTIs).
Dolutegravir works by blocking the HIV integrase enzyme, which the virus needs to insert its genetic material into human cells. By preventing this integration, Dolutegravir stops the virus from replicating and spreading throughout the body.
Dolutegravir is an integrase strand transfer inhibitor (INSTI) that prevents HIV from integrating into the host cell genome, making it one of the most effective antiretroviral drug classes available.
Achieves undetectable viral load faster than many other antiretrovirals
Minimal side effects with good quality of life for patients
Requires multiple mutations for resistance development
Convenient dosing schedule improves treatment adherence
The World Health Organization (WHO) recommends Dolutegravir-based regimens as:
This global endorsement reflects Dolutegravir's superior efficacy, safety profile, and accessibility in treating HIV worldwide.
Our manufacturing facilities meet the highest international quality standards set by the World Health Organization.
Supplying Dolutegravir tablets to over 50 countries, making life-saving HIV treatment accessible globally.
State-of-the-art facilities with 500 million tablets annual capacity ensuring consistent supply.
Rigorous testing and quality control at every stage of manufacturing ensures product excellence.
Strength: 50mg tablets
Indication: Adult and adolescent HIV treatment
Dosage: One tablet once daily
Packaging: Blister packs of 30 tablets
View DetailsStrength: 10mg dispersible tablets
Indication: Pediatric HIV treatment
Dosage: Weight-based dosing
Packaging: Blister packs of 30 tablets
View DetailsContact our team for detailed information about our Dolutegravir products, bulk orders, or partnership opportunities.